12 February 2018

ASX ANNOUNCEMENT

MVP signs major deal with Walgreens in the USA

Medical Developments International Limited (ASX: MVP) is delighted to announce that it has finalised a 'Ranging' deal with Walgreens in the USA. Walgreens is the second-largest pharmacy store chain in the United States with almost 9,000 stores. It is a subsidiary of Walgreens Boots Alliance Inc. which is the biggest healthcare pharmacy business in the world and includes the BOOT's pharmacy business in the United Kingdom. At the same time as concluding the agreement, Walgreens placed their first orders for stock and are distributing MVP product onto pharmacy shelves.

For further details please refer to the following link for the full announcement - ASX Announcement - MVP signs major deal with Walgreens

Medical Developments International Limited published this content on 12 February 2018 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 12 February 2018 03:35:04 UTC.

Original documenthttp://www.medicaldev.com/news/mvp-signs-major-deal-walgreens-usa/

Public permalinkhttp://www.publicnow.com/view/8A171676AABD879ACE497A06001371000D321BA0